$CPIX
CUMBERLAND PHARMACEUTICALS INC

2022 Q3 Form 10-Q Financial Statement

#000162828022022735 Filed on August 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2021 Q4
Revenue $11.41M $10.30M $8.320M
YoY Change 41.38% 13.73% -18.92%
Cost Of Revenue $2.224M $2.032M $2.225M
YoY Change 67.5% 16.73% 7.5%
Gross Profit $9.189M $8.267M $6.095M
YoY Change 36.24% 13.02% -25.68%
Gross Profit Margin 80.51% 80.27% 73.25%
Selling, General & Admin $6.277M $6.761M $6.719M
YoY Change 7.47% 8.71% -6.56%
% of Gross Profit 68.31% 81.78% 110.24%
Research & Development $1.714M $1.824M $1.613M
YoY Change 17.91% 34.06% 15.2%
% of Gross Profit 18.66% 22.06% 26.46%
Depreciation & Amortization $1.545M $1.618M $1.077M
YoY Change 43.86% 32.05% -12.43%
% of Gross Profit 16.81% 19.58% 17.67%
Operating Expenses $7.991M $8.584M $9.349M
YoY Change 9.55% 13.26% -4.02%
Operating Profit -$288.6K -$1.847M -$4.354M
YoY Change -81.54% 28.61% 149.38%
Interest Expense $149.3K $137.6K -$21.06K
YoY Change 645.92% 432.21% -29.8%
% of Operating Profit
Other Income/Expense, Net $0.00 $611.3K $0.00
YoY Change -72.05%
Pretax Income -$416.3K -$1.358M -$4.375M
YoY Change -73.58% -285.45% 145.79%
Income Tax $6.900K $6.900K $12.52K
% Of Pretax Income
Net Earnings -$408.6K -$1.336M -$3.848M
YoY Change -61.28% -208.71% 335.37%
Net Earnings / Revenue -3.58% -12.97% -46.25%
Basic Earnings Per Share -$0.03 -$0.09 -$0.26
Diluted Earnings Per Share -$0.03 -$0.09 -$0.26
COMMON SHARES
Basic Shares Outstanding 14.66M shares 14.69M shares 14.81M shares
Diluted Shares Outstanding 14.48M shares 14.69M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $19.54M $18.22M $27.04M
YoY Change -24.38% -29.04% 9.04%
Cash & Equivalents $19.54M $18.22M $27.04M
Short-Term Investments
Other Short-Term Assets $3.739M $2.835M $3.340M
YoY Change 196.95% 61.26% 51.82%
Inventory $10.65M $9.420M $8.430M
Prepaid Expenses
Receivables $15.23M $13.28M $6.877M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $49.16M $43.75M $45.69M
YoY Change 4.12% -6.28% -8.57%
LONG-TERM ASSETS
Property, Plant & Equipment $490.8K $457.5K $442.6K
YoY Change -0.54% -7.25% -22.91%
Goodwill $1.933M $1.933M $882.0K
YoY Change 119.15% 119.15% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.427M $2.537M $3.420M
YoY Change -26.5% -27.34% 5.74%
Total Long-Term Assets $41.62M $48.77M $38.77M
YoY Change 3.12% 15.65% -16.61%
TOTAL ASSETS
Total Short-Term Assets $49.16M $43.75M $45.69M
Total Long-Term Assets $41.62M $48.77M $38.77M
Total Assets $90.78M $92.52M $84.46M
YoY Change 3.66% 4.13% -12.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.51M $10.59M $9.641M
YoY Change 24.66% 18.17% -28.03%
Accrued Expenses $229.6K $512.3K $8.668M
YoY Change -79.02% -52.02% -22.98%
Deferred Revenue $0.00
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $25.31M $24.25M $19.28M
YoY Change 41.02% 30.06% -24.89%
LONG-TERM LIABILITIES
Long-Term Debt $17.70M $19.00M $15.00M
YoY Change 18.0% 35.71% 0.0%
Other Long-Term Liabilities $9.279M $10.06M $7.489M
YoY Change 16.29% 19.83% -4.76%
Total Long-Term Liabilities $26.98M $29.06M $7.489M
YoY Change 17.41% 29.76% -4.76%
TOTAL LIABILITIES
Total Short-Term Liabilities $25.31M $24.25M $19.28M
Total Long-Term Liabilities $26.98M $29.06M $7.489M
Total Liabilities $52.29M $53.31M $41.86M
YoY Change 27.76% 29.9% -15.59%
SHAREHOLDERS EQUITY
Retained Earnings -$8.768M -$8.359M -$5.639M
YoY Change 389.59% 1036.38% 164.6%
Common Stock $47.53M $47.82M $48.45M
YoY Change -2.22% -1.78% -1.36%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $38.76M $39.46M $42.81M
YoY Change
Total Liabilities & Shareholders Equity $90.78M $92.52M $84.46M
YoY Change 3.66% 4.13% -12.44%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2021 Q4
OPERATING ACTIVITIES
Net Income -$408.6K -$1.336M -$3.848M
YoY Change -61.28% -208.71% 335.37%
Depreciation, Depletion And Amortization $1.545M $1.618M $1.077M
YoY Change 43.86% 32.05% -12.43%
Cash From Operating Activities $2.635M $2.331M $1.960M
YoY Change -2683.4% -13.52% 127.87%
INVESTING ACTIVITIES
Capital Expenditures -$218.6K -$172.6K -$79.36K
YoY Change 101.89% 268.39% -62.21%
Acquisitions
YoY Change
Other Investing Activities $899.4K $0.00 $52.57K
YoY Change -152.57%
Cash From Investing Activities $680.8K -$172.6K -$26.79K
YoY Change -728.92% 268.39% -91.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.991M -1.208M -735.3K
YoY Change -619.86% -36.45% -69.74%
NET CHANGE
Cash From Operating Activities 2.635M 2.331M 1.960M
Cash From Investing Activities 680.8K -172.6K -26.79K
Cash From Financing Activities -1.991M -1.208M -735.3K
Net Change In Cash 1.325M 949.8K 1.198M
YoY Change 666.95% 27.2% -163.36%
FREE CASH FLOW
Cash From Operating Activities $2.635M $2.331M $1.960M
Capital Expenditures -$218.6K -$172.6K -$79.36K
Free Cash Flow $2.854M $2.503M $2.039M
YoY Change 45635.26% -8.7% 90.56%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001087294
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33637
dei Entity Registrant Name
EntityRegistrantName
Cumberland Pharmaceuticals Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
TN
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
62-1765329
dei Entity Address Address Line1
EntityAddressAddressLine1
2525 West End Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 950
dei Entity Address City Or Town
EntityAddressCityOrTown
Nashville
dei Entity Address State Or Province
EntityAddressStateOrProvince
TN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
37203
dei City Area Code
CityAreaCode
615
dei Local Phone Number
LocalPhoneNumber
255-0068
dei Security12b Title
Security12bTitle
Common stock, no par value
dei Trading Symbol
TradingSymbol
CPIX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14661937 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18216565 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27040816 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13276009 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6877346 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
9420459 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
8429882 usd
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
2835465 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3339969 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
43748498 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
45688013 usd
CY2022Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
10374054 usd
CY2021Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
9048567 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
457490 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
442635 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
32975117 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
23954475 usd
CY2022Q2 us-gaap Goodwill
Goodwill
1932876 usd
CY2021Q4 us-gaap Goodwill
Goodwill
882000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
493102 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1024200 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1024200 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2536500 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3419908 usd
CY2022Q2 us-gaap Assets
Assets
92517637 usd
CY2021Q4 us-gaap Assets
Assets
84459798 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
10591585 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
9640980 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
512324 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
969677 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
969677 usd
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
13148060 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8668303 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
24251969 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
19278960 usd
CY2022Q2 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
19000000 usd
CY2021Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
15000000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
90016 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
90016 usd
CY2022Q2 cpix Other Long Term Obligations Excluding Current Portion
OtherLongTermObligationsExcludingCurrentPortion
10061376 usd
CY2021Q4 cpix Other Long Term Obligations Excluding Current Portion
OtherLongTermObligationsExcludingCurrentPortion
7488844 usd
CY2022Q2 us-gaap Liabilities
Liabilities
53313345 usd
CY2021Q4 us-gaap Liabilities
Liabilities
41857820 usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2021Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14649693 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14649693 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14742754 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14742754 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
47822319 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
48452906 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8359473 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5638600 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
39462846 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
42814306 usd
CY2022Q2 us-gaap Minority Interest
MinorityInterest
-258554 usd
CY2021Q4 us-gaap Minority Interest
MinorityInterest
-212328 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
39204292 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
42601978 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
92517637 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
84459798 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10299152 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9055483 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21474197 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19592642 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2031884 usd
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1740649 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4243769 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4157978 usd
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4556685 usd
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4121817 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9171114 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7909157 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1823693 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1360398 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3568829 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2617765 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2203975 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2097130 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4506324 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4327639 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1529453 usd
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1171218 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3122698 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2340132 usd
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
12145690 usd
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
10491212 usd
us-gaap Costs And Expenses
CostsAndExpenses
24612734 usd
us-gaap Costs And Expenses
CostsAndExpenses
21352671 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1846538 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1435729 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3138537 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1760029 usd
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
15066 usd
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
6591 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
31107 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
12017 usd
CY2022Q2 us-gaap Other Income
OtherIncome
0 usd
CY2021Q2 us-gaap Other Income
OtherIncome
2187140 usd
us-gaap Other Income
OtherIncome
0 usd
us-gaap Other Income
OtherIncome
2187140 usd
CY2022Q2 us-gaap Insured Event Gain Loss
InsuredEventGainLoss
611330 usd
CY2021Q2 us-gaap Insured Event Gain Loss
InsuredEventGainLoss
0 usd
us-gaap Insured Event Gain Loss
InsuredEventGainLoss
611330 usd
us-gaap Insured Event Gain Loss
InsuredEventGainLoss
0 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
137624 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
25859 usd
us-gaap Interest Expense
InterestExpense
257199 usd
us-gaap Interest Expense
InterestExpense
50276 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1357766 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
732143 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2753299 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
388852 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6900 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7459 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13800 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14917 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1364666 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
724684 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-2767099 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
373935 usd
CY2022Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 usd
CY2021Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
498807 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
994217 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-1364666 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
1223491 usd
us-gaap Profit Loss
ProfitLoss
-2767099 usd
us-gaap Profit Loss
ProfitLoss
1368152 usd
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-29046 usd
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-5069 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-46226 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-27236 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1335620 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
1228560 usd
us-gaap Net Income Loss
NetIncomeLoss
-2720873 usd
us-gaap Net Income Loss
NetIncomeLoss
1395388 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.09
CY2021Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.05
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.19
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.02
CY2022Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2021Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.03
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.07
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.09
CY2021Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.05
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.19
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.02
CY2022Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2021Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.03
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.07
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.19
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14688505 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14976064 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14689798 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14970241 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14688505 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15109246 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14689798 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15171589 shares
us-gaap Profit Loss
ProfitLoss
-2767099 usd
us-gaap Profit Loss
ProfitLoss
1368152 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
994217 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-2767099 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
373935 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3272085 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2455576 usd
us-gaap Share Based Compensation
ShareBasedCompensation
132148 usd
us-gaap Share Based Compensation
ShareBasedCompensation
354914 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-68334 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-180110 usd
us-gaap Insured Event Gain Loss
InsuredEventGainLoss
611330 usd
us-gaap Insured Event Gain Loss
InsuredEventGainLoss
0 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
4791 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
27666 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2187140 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5527690 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3230220 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2949443 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2309914 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1227030 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-866987 usd
cpix Increase Decrease In Current Operating Liabilities
IncreaseDecreaseInCurrentOperatingLiabilities
4658782 usd
cpix Increase Decrease In Current Operating Liabilities
IncreaseDecreaseInCurrentOperatingLiabilities
-3008323 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-1688143 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-526189 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
2180038 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
3490553 usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
0 usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
994217 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2180038 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4484770 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
164241 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
34531 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
200000 usd
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
13500000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27040816 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24753796 usd
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
0 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
50248 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
132323 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13714489 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-366854 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
39000000 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
29000000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
35000000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
30000000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
501505 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
1423586 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
788295 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
777664 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2710200 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3201250 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8824251 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
916666 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
40793403 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
40793403 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18216565 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25670462 usd
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
46873394 usd
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
162960 usd
CY2021Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
303088 usd
CY2021Q1 us-gaap Profit Loss
ProfitLoss
144661 usd
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
46877927 usd
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
46877927 usd
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
191954 usd
CY2021Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
484965 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
1223491 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
47808407 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
42601978 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
159901 usd
CY2022Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
566043 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-1402433 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-2767099 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
373935 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-27753 usd
CY2022Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
196692 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-1364666 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
39204292 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Use of Estimates</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management of the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates under different assumptions and conditions. The Company's most significant estimates include: (1) its allowances for chargebacks and accruals for rebates and product returns, (2) the allowances for obsolescent or unmarketable inventory and (3) valuation of contingent consideration liabilities associated with business combinations.</span></div>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2022Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1364666 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
724684 usd
CY2022Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 usd
CY2021Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
498807 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-1364666 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
1223491 usd
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-29046 usd
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-5069 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1335620 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
1228560 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14688505 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14976064 shares
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2021Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
133182 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14688505 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15109246 shares
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
994217 usd
us-gaap Profit Loss
ProfitLoss
-2767099 usd
us-gaap Profit Loss
ProfitLoss
1368152 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-46226 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-27236 usd
us-gaap Net Income Loss
NetIncomeLoss
-2720873 usd
us-gaap Net Income Loss
NetIncomeLoss
1395388 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14689798 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14970241 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
201348 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14689798 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15171589 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
289975 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
198300 shares
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10299152 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9055483 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21474197 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19592642 usd
CY2022Q2 cpix Revenue Recognition Milestone Payments
RevenueRecognitionMilestonePayments
300000 usd
cpix Revenue Recognition Milestone Payments
RevenueRecognitionMilestonePayments
500000 usd
CY2022Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1000000 usd
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1400000 usd
CY2022Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
10400000 usd
CY2021Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
9000000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
9420459 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
8429882 usd
CY2022Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
12773497 usd
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
12374983 usd
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
12374983 usd
CY2022Q2 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
154266 usd
CY2021Q4 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
164378 usd
CY2021Q4 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
164378 usd
CY2022Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
6866750 usd
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4939088 usd
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4939088 usd
CY2022Q2 us-gaap Inventory Gross
InventoryGross
19794513 usd
CY2021Q4 us-gaap Inventory Gross
InventoryGross
17478449 usd
CY2022Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
10374054 usd
CY2021Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
9048567 usd
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0742
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y6M
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
493102 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1024200 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1024200 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
512324 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
969677 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
969677 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
90016 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
90016 usd
CY2022Q2 cpix Lease Liability
LeaseLiability
512324 usd
CY2021Q4 cpix Lease Liability
LeaseLiability
1059693 usd
CY2022Q2 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
300000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
441014 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
92477 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
533491 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
21167 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
512324 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
574071 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
605130 usd
us-gaap Sublease Income
SubleaseIncome
296237 usd
us-gaap Sublease Income
SubleaseIncome
348411 usd
CY2017Q4 cpix Stock Issued During Period Shelf Registration Proceeds From Saleof Corporate Securities
StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities
100000000 usd
CY2021Q4 cpix Stock Issued During Period Shelf Registration Proceeds From Saleof Corporate Securities
StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities
19000000 usd
CY2021Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
15000000 usd
CY2022Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
44100000 usd
CY2022Q2 us-gaap Insured Event Gain Loss
InsuredEventGainLoss
600000 usd
CY2019 cpix Financial Consideration Payment Period
FinancialConsiderationPaymentPeriod
P2Y
CY2020 cpix Financial Consideration Number Of Installments
FinancialConsiderationNumberOfInstallments
4 installment
CY2020 cpix Proceeds From Sale Of Intangible Assets Installment Payment
ProceedsFromSaleOfIntangibleAssetsInstallmentPayment
3000000 usd
CY2021 cpix Financial Consideration Number Of Installments
FinancialConsiderationNumberOfInstallments
4 installment
CY2022Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 usd
CY2021Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
498807 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
994217 usd

Files In Submission

Name View Source Status
0001628280-22-022735-index-headers.html Edgar Link pending
cpix-20220630_cal.xml Edgar Link unprocessable
0001628280-22-022735-index.html Edgar Link pending
0001628280-22-022735.txt Edgar Link pending
0001628280-22-022735-xbrl.zip Edgar Link pending
a2022q2-exhibit311.htm Edgar Link pending
a2022q2-exhibit312.htm Edgar Link pending
a2022q2-exhibit321.htm Edgar Link pending
cpix-20220630.htm Edgar Link pending
cpix-20220630.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
imagea.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
pinnaclebank-cpiamend8tolo.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
cpix-20220630_def.xml Edgar Link unprocessable
cpix-20220630_lab.xml Edgar Link unprocessable
cpix-20220630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cpix-20220630_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending